Positive results from the first study of high-dose influenza vaccine with a COVID-19 mRNA booster support co-administration recommendations
The Pharma Data
OCTOBER 6, 2021
First study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older Timely new data for the start of the influenza vaccination campaigns across the Northern Hemisphere. About the study.
Let's personalize your content